Clinical Trial

Non-Invasive Brain Stimulation and Migraines

Study Description

Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)

This study investigates whether non-invasive brain stimulation, given for 20 minutes/once per day for ten days (M-F) can reduce migraine pain. Thirty patients will receive this treatment, while thirty will receive a "sham" procedure. Up to thirty healthy volunteers will be asked to undergo baseline assessments only (imaging, but no brain stimulation). Healthy volunteer data may be used from a prior study (NINDS-K23062946 project [IRBMED #HUM00027383; Dr. Alexandre DaSilva, Principal Investigator]).

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - Active Comparator

non-invasive brain stimulation (active protocol)

Device - Sham Comparator

non-invasive brain stimulation (sham protocol)

Additional Information

Official Study Title

Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)

Clinical Trial ID

NCT02964741

ParticipAid ID

DdwA1a